Iwata H - Search Results

1

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer.

Iwata H, Masuda N, Kim SB, Inoue K, Rai Y, Fujita T, Chiu J, Ohtani S, Takahashi M, Miyaki T, Lu YS, Xu B, Yap YS, Bustam A, Yao B, Zhang B, Bryce R, Chan A. Iwata H, et al. Future Oncol. 2019 Jul;15(21):2489-2501. doi: 10.2217/fon-2019-0143. Epub 2019 May 29. Future Oncol. 2019. PMID: 31140297 Clinical Trial.

2

Low expression of the snail gene is a good prognostic factor in node-negative invasive ductal carcinomas.

Toyama T, Zhang Z, Iwase H, Yamashita H, Ando Y, Hamaguchi M, Mizutani M, Kondo N, Fujita T, Fujii Y, Iwata H. Toyama T, et al. Among authors: iwata h. Jpn J Clin Oncol. 2006 Jun;36(6):357-63. doi: 10.1093/jjco/hyl038. Epub 2006 Jun 9. Jpn J Clin Oncol. 2006. PMID: 16766568

3

Perspective of trastuzumab treatment.

Iwata H. Iwata H. Breast Cancer. 2007;14(2):150-5. doi: 10.2325/jbcs.955. Breast Cancer. 2007. PMID: 17485899 Free article. Review.

4

[Effectiveness of breast ultrasound].

Mizutani M, Takada H, Ando Y, Fujita T, Iwata H. Mizutani M, et al. Among authors: iwata h. Nihon Rinsho. 2007 Jun 28;65 Suppl 6:298-303. Nihon Rinsho. 2007. PMID: 17682171 Review. Japanese. No abstract available.

5

[Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)].

Masuda N, Toi M, Takatsuka Y, Nakamura S, Iwata H, Ohno S, Kuroi K, Kusama M, Hisamatsu K, Yamazaki K, Eisei S, Sato Y, Kaise H, Kashiwaba M, Iwase H, Kurosumi M, Tsuda H, Akiyama F; Japan Breast Cancer Research Group. Masuda N, et al. Among authors: iwata h. Gan To Kagaku Ryoho. 2007 Oct;34(10):1609-15. Gan To Kagaku Ryoho. 2007. PMID: 17940375 Japanese.

6

Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer.

Saji S, Toi M, Morita S, Iwata H, Ito Y, Ohno S, Kobayashi T, Hozumi Y, Sakamoto J. Saji S, et al. Among authors: iwata h. Oncology. 2007;72(5-6):330-7. doi: 10.1159/000113062. Epub 2008 Jan 12. Oncology. 2007. PMID: 18187954 Clinical Trial.

7

A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.

Hayashi H, Kimura M, Yoshimoto N, Tsuzuki M, Tsunoda N, Fujita T, Yamashita T, Iwata H. Hayashi H, et al. Among authors: iwata h. Breast Cancer. 2009;16(2):136-40. doi: 10.1007/s12282-008-0060-1. Epub 2008 Jun 12. Breast Cancer. 2009. PMID: 18548321

8

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: iwata h. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

9

Neo(adjuvant) trastuzumab treatment: current perspectives.

Iwata H. Iwata H. Breast Cancer. 2009;16(4):288-94. doi: 10.1007/s12282-009-0131-y. Epub 2009 Jul 17. Breast Cancer. 2009. PMID: 19609648 Review.

10

Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.

Yoshimoto N, Yamashita T, Fujita T, Hayashi H, Tsunoda N, Kimura M, Tsuzuki N, Yamashita H, Toyama T, Kondo N, Iwata H. Yoshimoto N, et al. Among authors: iwata h. Breast Cancer. 2010 Oct;17(4):298-302. doi: 10.1007/s12282-009-0171-3. Epub 2009 Sep 30. Breast Cancer. 2010. PMID: 19789949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,961 results

Search Page